Singapore markets closed

IRADIMED CORPORATION (IRMD)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
43.61-0.37 (-0.84%)
As of 09:55AM EDT. Market open.
Currency in USD

Valuation measures4

Market cap (intra-day) 556.97M
Enterprise value 513.78M
Trailing P/E 31.41
Forward P/E 28.57
PEG ratio (5-yr expected) N/A
Price/sales (ttm)8.28
Price/book (mrq)7.32
Enterprise value/revenue 7.59
Enterprise value/EBITDA 23.80

Trading information

Stock price history

Beta (5Y monthly) 0.84
52-week change 3-5.72%
S&P500 52-week change 325.87%
52-week high 350.85
52-week low 336.12
50-day moving average 342.88
200-day moving average 342.99

Share statistics

Avg vol (3-month) 348.11k
Avg vol (10-day) 362.01k
Shares outstanding 512.66M
Implied shares outstanding 612.66M
Float 87.16M
% held by insiders 137.04%
% held by institutions 154.60%
Shares short (14 Jun 2024) 4133.98k
Short ratio (14 Jun 2024) 42.95
Short % of float (14 Jun 2024) 41.68%
Short % of shares outstanding (14 Jun 2024) 41.06%
Shares short (prior month 15 May 2024) 497.61k

Dividends & splits

Forward annual dividend rate 40.6
Forward annual dividend yield 41.36%
Trailing annual dividend rate 30.15
Trailing annual dividend yield 30.34%
5-year average dividend yield 4N/A
Payout ratio 410.71%
Dividend date 330 May 2024
Ex-dividend date 417 May 2024
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 26.48%
Operating margin (ttm)26.98%

Management effectiveness

Return on assets (ttm)15.87%
Return on equity (ttm)25.52%

Income statement

Revenue (ttm)67.69M
Revenue per share (ttm)5.36
Quarterly revenue growth (yoy)13.70%
Gross profit (ttm)N/A
EBITDA 21.59M
Net income avi to common (ttm)17.92M
Diluted EPS (ttm)1.40
Quarterly earnings growth (yoy)21.40%

Balance sheet

Total cash (mrq)45.13M
Total cash per share (mrq)3.56
Total debt (mrq)1.94M
Total debt/equity (mrq)2.55%
Current ratio (mrq)9.44
Book value per share (mrq)6.01

Cash flow statement

Operating cash flow (ttm)12.7M
Levered free cash flow (ttm)6.76M